Late-onset and Recurrent Neonatal Group B Streptococcal Disease Associated with Breast-milk Transmission

2003 ◽  
Vol 6 (3) ◽  
pp. 251-256 ◽  
Author(s):  
Michael Kotiw ◽  
Gwang W. Zhang ◽  
Grant Daggard ◽  
Elizabeth Reiss-Levy ◽  
John W. Tapsall ◽  
...  

The purpose of the study was to determine the epidemiological relationships in three unrelated cases of neonatal late-onset Group B streptococcal (GBS) disease and maternal breast-milk infection with GBS. All deliveries were by cesarean section; case 1 was at term, and cases 2 and 3 were at 32- and 33-wk gestation, respectively. Case 1 relates to a mother with clinical mastitis and recurrent GBS infection in a 20-day-old male infant. Following antibiotic therapy and cessation of breastfeeding, the infant recovered without sequelae. Case 2 refers to a mother with clinical mastitis and the occurrence of late-onset GBS disease in 5-wk-old male twins. Despite intervention, one infant died and the second became ill. Following antibiotic therapy and cessation of breast-feeding, the surviving infant recovered without sequelae. Case 3 refers to a mother with sub-clinical mastitis and late-onset GBS infection occurring in a 6-day-old female twin. Following intervention, the infant recovered but suffered a bilateral thalamic infarction resulting in developmental delay and a severe seizure disorder. Following recovery of GBS from an inapparent mastitis and cessation of breast-feeding, the second infant remained well. Blood cultures from all affected infants and maternal breast milk were positive for GBS. Epidemiological relationships between neonatal- and maternal-derived GBS isolates were confirmed by a random amplified polymorphic DNA polymerase chain reaction assay (RAPD-PCR). This study is significant in that it has demonstrated that maternal milk (in cases of either clinical or sub-clinical mastitis) can be a potential source of infection resulting in either late-onset or recurrent neonatal GBS disease.

2017 ◽  
Vol 6 (3) ◽  
pp. 192
Author(s):  
Zakariya Al-Salam ◽  
SoumyaR Thomas ◽  
Tasnim Dawoud ◽  
Iman Doss

Author(s):  
Ziyaad Dangor ◽  
Mahtaab Khan ◽  
Gaurav Kwatra ◽  
Alane Izu ◽  
Firdose Nakwa ◽  
...  

Abstract Background Animal-model studies have demonstrated less group B streptococcal (GBS) invasive disease and gastrointestinal colonization after enteral administration of serotype-specific capsular antibodies. There is, however, a paucity of information on the association of breast milk GBS serotype-specific capsular antibodies and risks for invasive disease in infants. The aim of this study was to explore the association between natural secretory immunoglobulin A (sIgA) capsular antibodies in breast milk and the occurrence of late-onset disease (LOD) in young infants. Methods A matched case-control study was undertaken in infants <3 months of age in Johannesburg, South Africa. Breast milk samples were collected on cases and controls matched for gestational age, maternal age, and human immunodeficiency virus status at time of enrollment. Capsular serotype Ia, Ib, III, and V sIgA antibody concentrations were measured using the fluorescence-based micro-bead immunosorbent assay. Results Breast milk samples were available for 31 LOD cases (8 serotype Ia and 23 serotype III), 21 recto-vaginally colonized matched controls (10 serotype Ia and 11 serotype III), and 84 serotype Ia and 105 serotype III noncolonized matched controls. Using a Bayesian model to estimate the probability of disease, there were 90% reductions in the risks of developing serotypes Ia and III LOD with sIgA concentrations ≥0.14 µg/mL and ≥2.52 µg/mL, respectively. Conclusions Breast milk sIgA capsular antibodies were associated with lower risks for LOD in young infants. The ability of GBS polysaccharide-protein conjugate vaccines currently under development to induce sIgA responses warrant investigation as potential mediators of protection against LOD.


2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Giangiacomo Nicolini ◽  
Martina Borellini ◽  
Vitaliana Loizzo ◽  
Roberta Creti ◽  
Luigi Memo ◽  
...  

2008 ◽  
Vol 168 (9) ◽  
pp. 1155-1158 ◽  
Author(s):  
Arnaud Gagneur ◽  
Geneviève Héry-Arnaud ◽  
Séverine Croly-Labourdette ◽  
Gisèle Gremmo-Feger ◽  
Sophie Vallet ◽  
...  

2014 ◽  
Vol 90 ◽  
pp. S84-S86 ◽  
Author(s):  
Micaela Brandolini ◽  
Marta Corbella ◽  
Patrizia Cambieri ◽  
Daniela Barbarini ◽  
Davide Sassera ◽  
...  

2020 ◽  
Author(s):  
Alberto Berardi ◽  
Caterina Spada ◽  
Roberta Creti ◽  
Cinzia Auriti ◽  
Lucia Gambini ◽  
...  

PEDIATRICS ◽  
1974 ◽  
Vol 54 (5) ◽  
pp. 643-644
Author(s):  
Rufino Ermocilla ◽  
George Cassady ◽  
Ricardo Ceballos

In this report, a premature black male infant was found at autopsy to have bilateral otitis media, mastoiditis, and suppurative meningitis due to group B beta-hemolytic streptococcus (GB-BHS). The pathogenetic pathway proposed for this early onset meningitis is of importance in late onset meningitis. This patient clearly demonstrates the critical importance of examining middle ear and mastoid, both clinically and at autopsy, in the neonate colonized with this organism.


PEDIATRICS ◽  
1980 ◽  
Vol 66 (6) ◽  
pp. 1030-1031
Author(s):  
Cynthia F. Mann

As breast-feeding becomes increasingly popular, physicians who prescribe drugs for the nursing mother must watch for adverse effects on the infant. At our hospital some mothers receive combination antibiotic treatment with ampicillin, gentamicin, and clindamycin for antepartum infections. None of these drugs has been reported to cause morbidity in the newborn following transfer in breast milk, and we have not routinely discontinued nursing when these drugs have been used. A recent case in our practice suggests a possible adverse effect of such maternal antibiotic therapy on the nursing neonate.


Sign in / Sign up

Export Citation Format

Share Document